SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000875320-04-000085
Filing Date
2004-07-26
Accepted
2004-07-26 10:54:40
Documents
2
Period of Report
2004-07-23

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 2869
2 attach_1.htm EX-24 1448
  Complete submission text file 0000875320-04-000085.txt   6110
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Issuer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST., ATTN: GENERAL COUNSEL CAMBRIDGE MA 02139
Business Address 617-444-6176
Emmens Matthew (Reporting) CIK: 0001298332 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-19319 | Film No.: 04930186